U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06841406) titled 'Budesonide As a Treatment for Functional Dyspepsia' on Feb. 11.
Brief Summary: This clinical study is being conducted to evaluate the investigational drug, Budesonide, for the treatment of functional dyspepsia. The goal of this study is to learn more about the effect of Budesonide on patients with functional dyspepsia. Budesonide is a well-known and commonly used drug, and is part of the recommended therapy for patients with inflammatory bowel diseases (Crohn's disease or ulcerative colitis). It is also used as inhalation therapy for respiratory conditions such as asthma and COPD. However, the effect of Budesonide in patients with f...